I-Mab hits the deal table with biopharma majors to talk partnerships and investments: report
I-Mab hits the deal table with biopharma majors to talk [...]
How exploiting a protective gene mutation might protect the brain from Alzheimer’s disease
How exploiting a protective gene mutation might protect the brain [...]
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a [...]
Here we go again: Eisai starts rolling FDA approval submission for Biogen-partnered Alzheimer’s drug
Here we go again: Eisai starts rolling FDA approval submission [...]
Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping
Valneva, hit by COVID contract chaos, sees Lyme disease vaccine [...]
With a phase 3 fail, Biohaven learned the hard way why AstraZeneca dropped a CNS drug in 2018
With a phase 3 fail, Biohaven learned the hard way [...]
Novel ‘nanosized’ drug carriers tamp down HIV in the brain and other remote tissues in mice
Novel ‘nanosized’ drug carriers tamp down HIV in the brain [...]
Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab
Syndax and Incyte, both reeling from cancer drug setbacks, pen [...]
Vaccine boost: Bavarian Nordic gets government support to join 2nd wave of COVID-19 jabs
Vaccine boost: Bavarian Nordic gets government support to join 2nd [...]
Kids suffer serious adverse reactions in AGTC gene therapy trial
Kids suffer serious adverse reactions in AGTC gene therapy trial [...]